Hear experts' takeaways from ACOG 2025 on menopause care, postpartum depression screening, and obesity management.
Nanette F Santoro, MD
Advertisement
Articles by Nanette F Santoro, MD
The nonhormonal neurokinin-3 receptor antagonist improved menopausal adiposity without appreciable impact on body weight or BMI, Santoro explained at 2025 ACOG meeting.
Advertisement
Latest Updated Articles
Women’s Health Takeaways for Primary Care: Expert Insights From ACOG 2025Published: June 6th 2025 | Updated:
Nanette Santoro, MD, Highlights Findings on Fezolinetant From Pooled Analysis of Phase 3 Skylight Development Program TrialsPublished: May 19th 2025 | Updated:
Advertisement
Advertisement
Trending on Patient Care Online
1
Adult Stimulant Use Accounts for Most Recent Growth in ADHD Prescribing in Canada
2
10 Questions on The Holiday Spirit
3
Retatrutide Achieves Up to 28.7% Weight Loss and Marked Knee Pain Reduction in Phase 3 TRIUMPH-4 Trial
4
FDA Clears First At-Home Brain-Stimulation Device for Major Depression
5
